Connection

Alicia Jenkins to Hypoglycemic Agents

Back to Details
This is a "connection" page, showing publications Alicia Jenkins has written about Hypoglycemic Agents.
Alicia Jenkins
Connection Strength
3.120
Hypoglycemic Agents
  1. Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes. Sci Rep. 2021 08 17; 11(1):16656.
    View in: PubMed
    Score: 0.620
  2. Suboptimal behaviour and knowledge regarding overnight glycaemia in adults with type 1 diabetes is common. Intern Med J. 2018 09; 48(9):1080-1086.
    View in: PubMed
    Score: 0.505
  3. An algorithm guiding patient responses to real-time-continuous glucose monitoring improves quality of life. Diabetes Technol Ther. 2011 Feb; 13(2):105-9.
    View in: PubMed
    Score: 0.299
  4. Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial. Diabetes Care. 2010 Jun; 33(6):1242-8.
    View in: PubMed
    Score: 0.281
  5. Insulin Pumps: Review of Technological Advancement in Diabetes Management. Am J Med Sci. 2019 11; 358(5):326-331.
    View in: PubMed
    Score: 0.135
  6. Glucose Control Using a Standard Versus an Enhanced Hybrid Closed Loop System: A Randomized Crossover Study. Diabetes Technol Ther. 2019 01; 21(1):56-58.
    View in: PubMed
    Score: 0.129
  7. Effect of 6 months of hybrid closed-loop insulin delivery in adults with type 1 diabetes: a randomised controlled trial protocol. BMJ Open. 2018 06 09; 8(6):e020274.
    View in: PubMed
    Score: 0.124
  8. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017 08; 5(8):597-609.
    View in: PubMed
    Score: 0.116
  9. Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose Suspend. Diabetes Technol Ther. 2017 07; 19(7):438-439.
    View in: PubMed
    Score: 0.116
  10. Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial. Diabetes Obes Metab. 2017 04; 19(4):509-516.
    View in: PubMed
    Score: 0.114
  11. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study. Diabetes Technol Ther. 2016 12; 18(12):772-783.
    View in: PubMed
    Score: 0.111
  12. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study. Crit Care Med. 2016 09; 44(9):1695-703.
    View in: PubMed
    Score: 0.110
  13. Therapeutic effects of PPARa agonists on diabetic retinopathy in type 1 diabetes models. Diabetes. 2013 Jan; 62(1):261-72.
    View in: PubMed
    Score: 0.084
  14. An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes. Diabetes Technol Ther. 2023 02; 25(2):108-115.
    View in: PubMed
    Score: 0.042
  15. Late Afternoon Vigorous Exercise Increases Postmeal but Not Overnight Hypoglycemia in Adults with Type 1 Diabetes Managed with Automated Insulin Delivery. Diabetes Technol Ther. 2022 Dec; 24(12):873-880.
    View in: PubMed
    Score: 0.042
  16. Upload and Review of Insulin Pump and Glucose Sensor Data by Adults with Type 1 Diabetes: A Clinic Audit. Diabetes Technol Ther. 2022 07; 24(7):531-534.
    View in: PubMed
    Score: 0.041
  17. A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes. Diabetes Care. 2022 01 01; 45(1):194-203.
    View in: PubMed
    Score: 0.040
  18. Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provision. Diabetes Res Clin Pract. 2021 Sep; 179:109000.
    View in: PubMed
    Score: 0.039
  19. Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections. Diabetes Technol Ther. 2021 06; 23(6):460-466.
    View in: PubMed
    Score: 0.037
  20. Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial. Diabetes Care. 2020 12; 43(12):3024-3033.
    View in: PubMed
    Score: 0.037
  21. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study. Diabetes Technol Ther. 2019 09; 21(9):499-506.
    View in: PubMed
    Score: 0.033
  22. HDL as a Target for Glycemic Control. Curr Drug Targets. 2017; 18(6):651-673.
    View in: PubMed
    Score: 0.028
  23. HDL-C and HDL-C/ApoA-I predict long-term progression of glycemia in established type 2 diabetes. Diabetes Care. 2014 Aug; 37(8):2351-8.
    View in: PubMed
    Score: 0.023
  24. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation. 2005 May 17; 111(19):2446-53.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.